Volitionrx ltd (VNRX)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Revenues
Service

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Revenues

0

-

0

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

-14

0

0

0

14

0

0

0

0

27

39

54

54

27

15

0

0

0

0

Operating Expenses
Professional fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,737

1,689

1,501

1,606

1,262

1,029

958

533

723

757

683

621

361

276

251

250

301

254

205

167

0

0

0

Salaries and office administrative fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,062

1,816

1,611

1,628

1,656

1,503

1,243

1,075

767

490

640

666

713

683

659

666

869

881

0

-

0

0

-

Salaries and office administrative fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Research and development

11,783

10,363

10,655

10,750

10,958

10,906

10,264

9,659

8,781

8,026

8,334

8,169

8,110

7,904

6,852

6,745

6,353

6,101

5,740

4,950

4,384

4,044

3,479

2,931

2,781

2,503

2,827

2,936

2,855

2,773

2,319

1,977

1,834

1,521

0

0

0

General and administrative

5,205

4,731

4,876

4,971

5,208

5,821

6,385

6,490

6,274

5,833

8,003

6,611

5,350

4,177

715

693

649

669

560

548

477

299

441

379

451

434

455

435

461

448

332

339

235

247

0

0

0

Sales and marketing

955

965

1,028

1,092

1,089

1,169

1,033

959

931

836

760

663

585

347

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Total Operating Expenses

17,944

16,060

16,560

16,815

17,256

17,897

17,682

17,110

15,987

14,696

14,139

13,743

13,276

12,430

11,618

11,106

10,148

10,005

9,220

8,031

7,063

5,952

5,761

4,909

4,906

4,575

4,358

4,332

4,228

4,138

0

0

0

-

-

0

0

Operating Loss

-17,926

-16,042

-16,543

-16,815

-17,256

-17,897

-17,682

-17,110

-15,987

-14,696

-14,139

-13,743

-13,276

-12,430

-11,618

-11,106

-10,148

-10,005

-9,234

-8,031

-7,063

-5,952

-5,747

-4,909

-4,906

-4,575

-4,358

-4,305

-4,189

-4,083

0

0

0

-

-

-

-

Other Income (Expenses)
Grant income

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on derivative remeasurement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

Interest expense

-130

-126

-160

-157

-164

-110

43

90

83

73

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grants received

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

143

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other expenses

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Grants received

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Other expenses

-

-196

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on derivative re-measurement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

339

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain / (loss) on derivative re-measurement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Total Other Expenses

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

470

1,444

-2,685

-965

-2,261

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Derivative expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Total Other Income (Expenses)

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Provision for Income Taxes

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-9

-4

-4

-4

4

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

Net Loss

-17,754

-16,099

-16,829

-17,125

-17,559

-18,008

-17,784

-17,200

-16,070

-14,769

-13,690

-13,276

-12,763

-11,905

-11,607

-11,091

-10,012

-9,530

-7,785

-10,716

-8,029

-8,213

-8,197

-3,350

0

-

0

0

-

-

-

-

-

-

-

0

-

Net Loss attributable to Non-Controlling Interest

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss attributable to VolitionRx Limited Stockholders

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Operating Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Net Loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-3,321

0

0

-

0

-

0

Other Comprehensive Income (Loss)
Foreign currency translation adjustments

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Comprehensive Loss

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency translation adjustments

-

-

586

231

-

-

196

118

47

63

-15

32

-96

-109

-52

-53

59

19

28

-6

-60

-44

-40

-27

-30

-25

-11

-11

-34

-38

0

0

0

-

-

-

-

Total Other Comprehensive Income/(Loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-52

-53

59

19

28

-6

-60

-44

-40

-27

-30

-25

-11

-11

-34

-38

0

0

0

-

-

-

-

Net Comprehensive Loss

-

-

-16,242

-16,893

-

-

-17,587

-17,081

-16,023

-14,705

-13,705

-13,244

-12,859

-12,014

-11,660

-11,144

-9,953

-9,510

-7,757

-10,722

-8,090

-8,257

-8,141

-3,160

-5,027

-3,735

-4,369

-4,316

-4,223

-4,121

0

0

0

-

-

-

-

Net Loss Per Share - Basic and Diluted attributable to VolitionRx Limited

-0.14

-0.08

-0.10

-0.11

-0.12

-0.11

-0.14

-0.15

-0.17

-0.15

-0.15

-0.13

-0.13

-0.11

-0.15

-0.13

-0.13

-0.16

-0.16

-0.10

-0.12

-

-

-

-0.18

-

-

-

-0.09

-0.16

-0.09

-0.10

-0.09

-0.12

-0.12

-0.13

-0.08

Weighted Average Shares Outstanding
Basic and Diluted

41,197

41,752

39,880

38,876

36,212

35,437

32,826

30,027

27,265

26,533

26,512

26,383

26,128

25,969

23,524

23,412

19,289

18,477

18,042

17,945

16,461

-

-

-

12,246

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss per Share - Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.44

0.06

-

-

-0.08

-0.10

-

-

-

-

-

-

-

-

-

Net Loss per Share - Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.44

0.06

-

-

-

-0.10

-

-

-

-

-

-

-

-

-

Weighted Average Shares Outstanding - Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,524

13,388

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted Average Shares Outstanding - Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,524

13,887

-

-

-

10,642

-

-

-

-

-

-

-

-

-

Weighted Average Shares Outstanding - Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

11,086

10,642

-

-

-

-

-

-

-

-

-

Weighted Average Shares Outstanding - Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,210

-

9,697

9,031

8,645

8,286

5,898

4,742

4,146